Inorine 40mg Injection
By Inorine
Rx
2ml Injection in a Vial

Composition
Drotaverine(40mg)

Manufacturer - Ind Swift Laboratories Ltd
SCO 850, Shivalik Enclave, N.A.C. Manimajra, Chandigarh - 160101 INDIA

Expires on or after
October, 2025

liver
Limited information is available on the safety of Inorine 40mg Injection in individuals with liver disease. It is important to consult with your doctor regarding the use of this medication if you have liver issues. Your healthcare provider can provide personalized guidance based on your specific health condition.

kidney
Limited information is known about the use of Inorine 40mg Injection in kidney disease patients. It is advised to consult your doctor before use.

alcohol
Consult your doctor when consuming alcohol with Inorine 40mg Injection.

driving
Inorine 40mg Injection may cause vertigo, affecting driving ability. Use caution when driving after taking Inorine 40mg Injection.

pregnancy
Information about the safety of using Inorine 40mg Injection during pregnancy is not provided. It is recommended to consult with your doctor before considering the use of this medication.

breastfeeding
It is better to consult your doctor before using Inorine 40mg Injection during breastfeeding.
Habit Forming | No |
Chemical Class | Papaverine Derivatives |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Phosphodiesterase-IV inhibitors (Smooth Muscle Relaxant) |
₹8.72
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025